<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Because of blood <z:chebi fb="23" ids="18059">lipid</z:chebi> concerns, <z:mp ids='MP_0002055'>diabetes</z:mp> associations discourage <z:chebi fb="15" ids="28757">fructose</z:chebi> at high intakes </plain></SENT>
<SENT sid="1" pm="."><plain>To quantify the effect of <z:chebi fb="15" ids="28757">fructose</z:chebi> on blood <z:chebi fb="23" ids="18059">lipids</z:chebi> in <z:mp ids='MP_0002055'>diabetes</z:mp>, we conducted a systematic review and meta-analysis of experimental clinical trials investigating the effect of isocaloric <z:chebi fb="15" ids="28757">fructose</z:chebi> exchange for carbohydrate on <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, total cholesterol, <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> in type 1 and 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We searched MEDLINE, EMBASE, CINAHL, and the Cochrane Library for relevant trials of &gt; or =7 days </plain></SENT>
<SENT sid="3" pm="."><plain>Data were pooled by the generic inverse variance method and expressed as standardized mean differences with 95% CI </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneity</z:hpo> was assessed by chi(2) tests and quantified by I(2) </plain></SENT>
<SENT sid="5" pm="."><plain>Meta-regression models identified dose threshold and independent predictors of effects </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Sixteen trials (236 subjects) met the eligibility criteria </plain></SENT>
<SENT sid="7" pm="."><plain>Isocaloric <z:chebi fb="15" ids="28757">fructose</z:chebi> exchange for carbohydrate raised <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and lowered total cholesterol under specific conditions without affecting <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> or <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>A <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-raising effect without <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> was seen only in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> when the reference carbohydrate was <z:chebi fb="99" ids="28017">starch</z:chebi> (mean difference 0.24 [95% CI 0.05-0.44]), dose was &gt;60 g/day (0.18 [0.00-0.37]), or follow-up was &lt; or =4 weeks (0.18 [0.00-0.35]) </plain></SENT>
<SENT sid="9" pm="."><plain>Piecewise meta-regression confirmed a dose threshold of 60 g/day (R(2) = 0.13)/10% energy (R(2) = 0.36) </plain></SENT>
<SENT sid="10" pm="."><plain>A total cholesterol-lowering effect without <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> was seen only in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> under the following conditions: no randomization and poor study quality (-0.19 [-0.34 to -0.05]), dietary fat &gt;30% energy (-0.33 [-0.52 to -0.15]), or crystalline <z:chebi fb="15" ids="28757">fructose</z:chebi> (-0.28 [-0.47 to -0.09]) </plain></SENT>
<SENT sid="11" pm="."><plain>Multivariate meta-regression analyses were largely in agreement </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Pooled analyses demonstrated conditional <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-raising and total cholesterol-lowering effects of isocaloric <z:chebi fb="15" ids="28757">fructose</z:chebi> exchange for carbohydrate in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>Recommendations and large-scale future trials need to address the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in the data </plain></SENT>
</text></document>